Analysis of SAT1 type foot-and-mouth disease virus capsid proteins: Influence of receptor usage on the properties of virus particles

Virus Research

Volumn 155, Issue 2, 2011, Pages 462-472

  Maree, Francois F ^a   Blignaut, Belinda ^a,b   Aschenbrenner, Lisa ^c   Burrage, Tom ^c   Rieder, Elizabeth ^c  

^a ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

^c PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

Author keywords

Foot and mouth disease virus; Heparan sulphate proteoglycan; Infectious cDNA; Integrin receptor; Recombinant virus

Indexed keywords

ACID; ALANINE; ALPHA INTEGRIN; BETA INTEGRIN; CAPSID PROTEIN; GLYCINE; INTEGRIN RECEPTOR; LYSINE; POLYSACCHARIDE SULFATE; PROTEIN VP1; PROTEIN VP3; SERINE; TYROSINE; VIRUS RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CHO CELL; FOOT AND MOUTH DISEASE VIRUS; KIDNEY EPITHELIUM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEROTYPE; SOUTH AFRICAN TERRITORY TYPE 1 VIRUS; TISSUE CULTURE; VIRAL TROPISM; VIRION; VIRUS CAPSID; VIRUS CULTURE; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS PLAQUE; VIRUS RECOMBINANT; VIRUS STRAIN; WILD TYPE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; CAPSID PROTEINS; CHO CELLS; CRICETINAE; CRICETULUS; FOOT-AND-MOUTH DISEASE VIRUS; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, VIRUS; SEQUENCE ALIGNMENT; VIRION;

AEPYCEROS MELAMPUS; FOOT-AND-MOUTH DISEASE VIRUS; MIRIDAE;

EID: 78751705993     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.12.002     Document Type: Article

References (58)

1. Amadori M., Berneri C., Archetti I.L. Immunogenicity of foot-and-mouth disease virus grown in BHK-21 suspension cells. Correlation with cell ploidy alterations and abnormal expression of the alpha 5 beta 1 integrin. Vaccine 1994, 12:159-166.
2. Amadori M., Volpe G., Defilippi P., Berneri C. Phenotypic features of BHK-21 cells used for production of foot-and-mouth disease vaccine. Biologicals 1997, 25:65-73.
3. Bachrach H.L. Foot-and-mouth disease. Annu. Rev. Microbiol. 1968, 22:201-244.
4. Baranowski E., Sevilla N., Verdaguer N., Ruiz-Jarabo C.M., Beck E., Domingo E. Multiple virulence determinants of foot-and-mouth disease virus in cell culture. J. Virol. 1998, 72(8):6362-6372.
5. Bastos A.D.S., Bertschinger H.J., Cordel C., Van Vuuren C.de W.J., Bengis R.G., Grobler D.G., Thomson G.R. Possibility of sexual transmission of foot-and-mouth disease from African buffalo to cattle. Vet. Rec. 1999, 17:77-79.
6. Bastos A.D.S., Haydon D.T., Forsberg R., Knowles N.J., Anderson E.C., Nel L.H., Thomson G.R., Bengis R.G. Genetic heterogeneity of SAT-1 type foot-an-d-mouth disease viruses in southern Africa. Arch. Virol. 2001, 146:1537-1551.
7. Bastos A.D.S., Haydon D.T., Sangare O., Boshoff C.I., Edrich J.L., Thomson G.R. The implications of virus diversity within the SAT 2 serotype for control of foot-and-mouth disease in sub-Saharan Africa. J. Gen. Virol. 2003, 84:1595-1606.
8. Bastos A.D.S., Anderson E.C., Bengis R.G., Keet D.F., Winterbach H.K., Thomson G.R. Molecular epidemiology of SAT3-type foot-and-mouth disease. Virus Genes 2003, 27:283-290.
9. Baxt B., Becker Y. The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells. Virus Genes 1990, 4:73-83.
10. Berinstein A., Roivainen M., Hovi T., Mason P.W., Baxt B. Antibodies to the victronectin receptor integrin αvβ3 inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J. Virol. 1995, 69:2664-2666.
11. Burman A., Clark S., Abrescia N.G., Fry E.E., Stuart D.I., Jackson T. Specificity of the VP1 GH loop of foot-and-mouth disease virus for αv integrins. J. Virol. 2006, 80:9798-9810.
12. Dawe P.S., Flanagan F.O., Madekurozwa R.L., Sorensen K.J., Anderson E.C., Foggin C.M., Ferris N.P., Knowles N.J. Natural transmission of foot-and-mouth disease virus from African buffalo (Syncerus caffer) to cattle in a wildlife area of Zimbabwe. Vet. Rec. 1994, 134:230-232.
13. Domingo E., Escarmis C., Martinez M.A., Martinez-Salas E., Mateu M.G. Foot-and-mouth disease virus populations are quasispecies. Curr. Top. Microbiol. Immunol. 1992, 176:33-47.
14. Domingo E. Quasispecies and the implications for virus persistence and escape. Clin. Diagn. Virol. 1998, 10:97-101.
15. Domingo E., Escarmis C., Lázaro E., Manrubia S.C. Quasispecies dynamics and RNA virus extinction. Virus Res. 2005, 107:129-139.
16. Duque H., Baxt B. FMDV receptors: comparison of bovine αv integrin utilization by type A and O viruses. J. Virol. 2003, 77:2500-2511.
17. Duque H., LaRocco M., Golde W.T., Baxt B. Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins. J. Virol. 2004, 78(18):9773-9781.
18. Esterhuysen J.J., Thomson G.R., Ashford W.A., Lentz D.W., Gainaru M.D., Sayer A.J., Meredith C.D., Janse van Rensburg D., Pini A. The suitability of a rolled BHK21 monolayer system for the production of vaccines against the SAT types of foot-and-mouth disease virus. I. Adaptation of virus isolates to the system, immunogen yields achieved and assessment of subtype cross reactivity. Onderstepoort. J. Vet. Res. 1988, 55(2):77-84.
19. Fox G., Parry N.R., Barnett P.V., McGinn B., Rowlands D.J., Brown F. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J. Gen. Virol. 1989, 70(Pt. 3):625-637.
20. Fry E.E., Lea S.M., Jackson T., Newman J.W.I., Ellard F.M., Blakemore W.E., Abu-Ghazaleh R., Samuel A., King A.M.Q., Stuart D.I. The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex. EMBO J. 1999, 18(3):543-554.
21. Fry E.E., Newman J.W.I., Curry S., Najjam S., Jackson T., Blakemore W., Lea S.M., Miller L., Burman A., King A.M.Q., Stuart D.I. Structure of FMDV serotype A1O61 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation. J. Gen. Virol. 2005, 86:1909-1920.
22. Gromm J.R., Hilemann R.E., Caldwell E.E.O., Weiler J.M., Linhardt R.J. Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. Arch. Biochem. Biophys. 1995, 323:279-287.
23. Heath L. Information on the distribution of SAT-type foot-and-mouth disease viruses in African buffalo (Syncerus caffer) populations 2008, Technical report to the Food, Agriculture and Natural Resources Directorate of the Southern African Development Community Secretariat.
24. Jackson T., Ellard F.M., Abu-Ghazaleh R., Brookes S.M., Blakemore W.E., Corteyn A.H., Stuart D.I., Newman J.W.I., King A.M.Q. Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate. J. Virol. 1996, 70:5282-5287.
25. Jackson T., Sharma A., Ghazaleh R.A., Blakemore W.E., Ellard F.M., Simmons D.L., Newman J.W.I., Stuart D., King A.M.Q. Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin αvβ3 in vitro. J. Virol. 1997, 71(11):8357-8361.
26. Jackson T., Sheppard D., Denyer M., Blakemore W., King A.M.Q. The epithelial integrin alpha-v-beta-6 is a receptor for foot-and-mouth disease virus. J. Virol. 2000, 74(11):4949-4956.
27. Jackson T., Mould A.P., Sheppard D., King A.M.Q. Integrin αvβ1 is a receptor for foot-and-mouth disease virus. J. Virol. 2002, 76:935-941.
28. Jackson T., Clarck S.J., Berryman S., Burman A., Cambier S., Mu D., Nishimura S., King A.M.Q. Integrin a αvβ8 functions as a receptor for foot-and-mouth disease virus: role of the b-chain cytodomain in integrin-mediated infection. J. Virol. 2004, 78:4533-4540.
29. Knipe T., Rieder E., Baxt B., Ward G., Mason P.W. Characterization of synthetic foot-and-mouth disease virus provirions separates acid-mediated disassembly from infectivity. J. Virol. 1997, 71:2851-2856.
30. Knowles N.J., Samuel A.R. Molecular epidemiology of foot-and-mouth disease virus. Virus Res. 2003, 91:65-80.
31. Logan D., Abu-Ghazaleh R., Blakemore W., Curry S., Jackson T., King A., Lea S., Lewis R., Newman J., Parry N., Rowlands D., Stuart D., Fry E. Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 1993, 362:566-568.
32. Maree F.F., Blignaut B., De Beer T.A.P., Visser N., Rieder E. Mapping of amino acid residues responsible for adhesion of cell culture-adapted foot-and-mouth disease SAT type viruses. Virus Res. 2010, 153:82-91.
33. Mason P.W., Rieder E., Baxt B. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:1932-1936.
34. Monaghan P., Gold S., Simpson J., Zhang Z., Weinreb P.H., Violette S.M., Alexandersen S., Jackson T. The αvβ6 integrin receptor for foot-and-mouth disease virus is expressed constitutively on the epithelial cells targeted in cattle. J. Gen. Virol. 2005, 86:2769-2780.
35. Neff S., Sa-Carvalho D., Rieder E., Mason P.W., Blystone S.D., Brown E.J., Baxt B. Foot-and-mouth disease virus virulent for cattle utilizes the integrin alpha(v)beta3 as its receptor. J. Virol. 1998, 72:3587-3594.
36. Neff S., Mason P.W., Baxt B. High-efficiency utilization of the bovine integrin αvβ3 as a receptor for foot-and-mouth disease virus is dependent on the bovine β3 subunit. J. Virol. 2000, 74:7298-7306.
37. Neff S., Baxt B. The ability of integrin alpha(v)beta(3) to function as a receptor for foot-and-mouth disease virus is not dependent on the presence of complete subunit cytoplasmic domains. J. Virol 2001, 75:527-532.
38. Office International des Epizooties Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2009, Office International des Epizooties, Paris, France, Chapter 2.1.5, pp 1-25.
39. Pay, T.W.F., Rweyemamu, M.M., O'Reilly, K.J., 1978. Experiences with Type SAT 2 foot-and-mouth disease vaccines in Southern Africa. XVth Conference of the Office International Des Epizzoties Permanent Commision on foot-and-mouth disease. pp 1-25.
40. Parry N., Fox G., Rowlands D., Brown F., Fry E., Acharya R., Logan D., Stuart D. Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature 1990, 347:569-572.
41. Pfaff E., Thiel H.-J., Beck E., Strohmaier K., Schaller H. Analysis of neutralizing epitopes on foot-and-mouth disease virus. J. Virol. 1988, 62(6):2033-2040.
42. Preston K.J., Owens H., Mowat G.N. Sources of variations encountered during the selection and production of three strains of FMD virus for the development of vaccine for use in Nigeria. J. Biol. Stand. 1982, 10:35-45.
43. Rieder E., Bunch T., Brown F., Mason P.W. Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice. J. Virol. 1993, 67:5139-5145.
44. Rieder E., Henry T., Duque H., Baxt B. Analysis of a foot-and-mouth disease type A24 isolate containing an SGD receptor recognition site in vitro and its pathogenesis in cattle. J. Virol. 2005, 79:12989-12998.
45. Rweyemamu M.M. The selection of vaccine strains of foot and mouth disease virus. Br. Vet. J. 1978, 134:63-67.
46. Sa-Carvalho D., Rieder E., Baxt B., Rodarte R., Tanuri A., Mason P.W. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J. Virol. 1997, 71:5115-5123.
47. Storey P., Theron J., Maree F.F., O'Neill H.G. A second RGD motif in the 1D capsid protein of a SAT1 type foot-and-mouth disease virus field isolate is not essential for attachment to target cells. Virus Res. 2007, 124(1-2):184-192.
48. Surovoǐ A., Ivanov V.T., Chepurkin A.V., Ivaniushchenkov V.N., Driagalin N.N. Is the Arg-Gly-Asp sequence the site for foot-and-mouth disease virus binding with cell receptor?. Bioorg. Khim. 1988, 14(7):965-968.
49. Sutmoller P. The fencing issue relative to the control of foot-and-mouth disease. Ann. N. Y. Acad. Sci. 2003, 191-200.
50. Thomson G.R., Vosloo W., Esterhuysen J.J., Bengis R.G. Maintenance of foot and mouth disease virus in buffalo (Syncerus caffer Sparrman, 1979) in Southern Africa. Rev. Sci. Tech. Off. Int. Epiz. 1992, 11:1097-1107.
51. Thomson G.R., Vosloo W., Bastos A.D.S. Foot and mouth disease in wildlife. Virus Res. 2003, 91:145-161.
52. Van Rensburg H.G., Nel L.H. Characterization of the structural-protein-coding region SAT 2 type foot-and-mouth disease virus. Virus Genes 1999, 19(3):229-233.
53. Van Rensburg H.G., Henry T., Mason P.W. Studies of genetically defined chimeras of a European type A virus and a South African Territories type 2 virus reveal growth determinants for foot-and-mouth disease virus. J. Gen. Virol. 2004, 85:61-68.
54. Vosloo W., Kirkbride E., Bengis R.G., Keet D.F., Thomson G.R. Genome variation in the SAT types of foot-and-mouth disease viruses prevalent in buffalo (Syncerus caffer) in the Kruger National Park and other regions of southern Africa, 1986-93. Epidemiol. Infect. 1995, 114:203-218.
55. Vosloo W., Bastos A.D., Kirkbride E., Esterhuysen J.J., Janse van Rensburg D., Bengis R.G., Keet D.F., Thomson G.R. Persistent infection of African buffalo (Syncerus caffer) with SAT type foot-and-mouth disease viruses: rate of fixation of mutations, antigenic change and interspecies transmission. J. Gen. Virol. 1996, 77:1457-1467.
56. Vosloo W., Bastos A.D., Michel A., Thomson G.R. Tracing movement of African buffalo in southern Africa. Rev. Sci. Tech. 2001, 20:630-639.
57. Vosloo W., Bastos A.D.S., Sangare O., Hargreaves S.K., Thomson G.R. Review of the status and control of foot and mouth disease in sub-Saharan Africa. Rev. Sci. Tech. Off. Int. Epiz. 2003, 21:437-449.
58. Zhao Q., Pacheco J.M., Mason P. Evaluation of genetically engineered derivatives of a chinese strain of foot-and-mouth disease virus reveals a novel cell-binding site which functions in cell culture and in animals. J. Virol. 2003, 77:3269-3280.